These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes. Kelley DE, Bidot P, Freedman Z, Haag B, Podlecki D, Rendell M, Schimel D, Weiss S, Taylor T, Krol A, Magner J. Diabetes Care; 1998 Dec; 21(12):2056-61. PubMed ID: 9839094 [Abstract] [Full Text] [Related]
5. Acarbose in NIDDM patients with poor control on conventional oral agents. A 24-week placebo-controlled study. Lam KS, Tiu SC, Tsang MW, Ip TP, Tam SC. Diabetes Care; 1998 Jul; 21(7):1154-8. PubMed ID: 9653611 [Abstract] [Full Text] [Related]
12. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Holman RR, Cull CA, Turner RC. Diabetes Care; 1999 Jun; 22(6):960-4. PubMed ID: 10372249 [Abstract] [Full Text] [Related]
13. Long-term effect of acarbose on glycaemic control in non-insulin-dependent diabetes mellitus: a placebo-controlled double-blind study. Hotta N, Kakuta H, Sano T, Matsumae H, Yamada H, Kitazawa S, Sakamoto N. Diabet Med; 1993 Mar; 10(2):134-8. PubMed ID: 8458189 [Abstract] [Full Text] [Related]
14. Clinical experience with acarbose: results of a Canadian multicentre study. Rodger NW, Chiasson JL, Josse RG, Hunt JA, Palmason C, Ross SA, Ryan EA, Tan MH, Wolever TM. Clin Invest Med; 1995 Aug; 18(4):318-24. PubMed ID: 8549019 [Abstract] [Full Text] [Related]
15. No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate. Wolever TM, Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH. Diabetes Care; 1998 Oct; 21(10):1612-8. PubMed ID: 9773719 [Abstract] [Full Text] [Related]
17. Acarbose for the treatment of type II diabetes: the results of a Canadian multi-centre trial. Josse RG. Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S167-72. PubMed ID: 8529510 [Abstract] [Full Text] [Related]
18. Double-blind crossover study of acarbose in type 1 diabetic patients. Marena S, Tagliaferro V, Cavallero G, Pagani A, Montegrosso G, Bianchi W, Zaccarini P, Pagano G. Diabet Med; 1991 Aug; 8(7):674-8. PubMed ID: 1833121 [Abstract] [Full Text] [Related]
19. Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study. Hoffmann J, Spengler M. Diabetes Care; 1994 Jun; 17(6):561-6. PubMed ID: 8082525 [Abstract] [Full Text] [Related]
20. One-year acarbose treatment raises fasting serum acetate in diabetic patients. Wolever TM, Radmard R, Chiasson JL, Hunt JA, Josse RG, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH. Diabet Med; 1995 Feb; 12(2):164-72. PubMed ID: 7743764 [Abstract] [Full Text] [Related] Page: [Next] [New Search]